ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.031,58
0,00%
S&P 500
5.283,40
0,11%
US Dollar vs BRL
5,26927
0,36%
Bitcoin
69.007,99
0,30%
Brent Oil
77,02
-1,43%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. USOTC
  6. CNBX Pharmaceuticals Inc (QB) (CNBX)

  7. CNBX Pharmaceuticals Inc (QB) (CNBX) Notícias

CNBX

CNBX Pharmaceuticals (QB) (CNBX)

CNBX Pharmaceuticals Inc (QB)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:CNBX
DataHoraFonteTítuloCódigoCompanhia
13/02/202418:27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
12/01/202412:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
14/04/202310:59Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
06/03/202319:04Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
08/02/202309:51Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
27/12/202209:50Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
18/02/202218:02Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
04/02/202210:26Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
18/05/202107:07Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
23/02/202117:28Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
04/11/202013:22Edgar (US Regulatory)Annual Report (10-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
14/01/201920:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
26/09/201809:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
12/09/201810:11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
29/11/201718:38Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
25/10/201710:45InvestorWireBiotechs Develop Proprietary Systems to Drive CBD Research and DevelopmentUSOTC:CNBXCNBX Pharmaceuticals Inc (QB)
30/08/201723:29InvestorsHub NewsWireMJAC 2017 Speaker Update - How venture capital and cryptocurrency are converging as the future of cannabis investingUSOTC:CNBXCNBX Pharmaceuticals Inc (QB)
28/08/201711:43InvestorsHub NewsWirePotNetwork Holdings, Inc Confirmed for MJAC 2017USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
25/08/201719:50InvestorsHub NewsWireMJAC 2017 International Cannabis Conference - Discount CodeUSOTC:CNBXCNBX Pharmaceuticals Inc (QB)
23/08/201713:50InvestorsHub NewsWireBook your ticket now for InvestorsHubs International Cannabis ConferenceUSOTC:CNBXCNBX Pharmaceuticals Inc (QB)
22/08/201702:27InvestorsHub NewsWireMJAC 2017 - Speaker Update - Investing In The U.S. Cannabis MarketUSOTC:CNBXCNBX Pharmaceuticals Inc (QB)
20/04/201710:00InvestorsHub NewsWireWhat Cannabis Stocks Investors Should Know and Coverage of a Mobile Tech Sub Penny StockUSOTC:CNBXCNBX Pharmaceuticals Inc (QB)
07/04/201710:44Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
21/03/201714:18Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
15/03/201713:52Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
08/02/201711:30InvestorWireIsraeli Innovation is at the Heart of a Growing Cannabis EcosystemUSOTC:CNBXCNBX Pharmaceuticals Inc (QB)
21/12/201617:05Edgar (US Regulatory)Report of Proposed Sale of Securities (144)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
08/04/201607:02Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
11/07/201416:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
01/05/201407:08Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
 Apresentando as notícias mais relevantes sobre:USOTC:CNBX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
OIBR3
OI ON
BOV
AMER3
Americanas ON
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
IDIV
Dividend
BOV
AZEV4
AZEVEDO PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados